EZH2‐mediated downregulation of miR‐155‐5p contributes to prostate cancer cell malignancy through SMAD2 and TAB2
Abstract miR‐155 exhibits variable expression in different tumors and fulfills diverse biological roles. However, specific molecular mechanisms by which miR‐155‐5p, which is under‐expressed in prostate cancer (PCa), operates are yet to be elucidated. The role of the enhancer of zeste 2 (EZH2)/miR‐15...
Saved in:
| Main Authors: | Zhi‐Jie Bai, Jia‐Yi Liu, Wen‐Zhou Xing, Hai‐Feng Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Kaohsiung Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/kjm2.12936 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miR-21 and miR-155 in the regulation of TGF-β1/SMAD signaling pathway of the line breast cancer cells with different metastatic potential
by: Z. N. Nikiphorova, et al.
Published: (2015-09-01) -
The epigenetic role of EZH2 in acute myeloid leukemia
by: Jinyong Fang, et al.
Published: (2024-12-01) -
Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential
by: Maria Saveria Gilardini Montani, et al.
Published: (2024-12-01) -
MicroRNA MiR-21 and MiR-155 are new markers for breast cancer
by: M. A. Taipov, et al.
Published: (2014-07-01) -
The diagnostic and predictive potential of lncRNA CASC2 targeting miR-155 in systemic lupus erythematosus patients with nephritis complication
by: Nada R. Mohamed, et al.
Published: (2024-12-01)